A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

February 19, 2025

Study Completion Date

December 5, 2026

Conditions

Pancreas CancerPancreatic Ductal AdenocarcinomaPancreatic Cancer

Interventions

DRUG

Ketorolac Tromethamine

Trial treatment of ketorolac 10mg orally four times a day for 5 consecutive days

Trial Locations (1)

Cedars- Sinai Medical Center, Los Angeles

All Listed Sponsors

collaborator

Yinuoke Ltd.

UNKNOWN

lead

Andrew Hendifar, MD

OTHER